GL-PCT G

  
Chapter I – Patentability
1.General disclaimer
2.General remarks
Chapter II – Inventions
1.General remarks
2.Examination practice
3.List of exclusions
3.1Discoveries
3.2Scientific theories
3.3Mathematical theories
3.4Aesthetic creations
3.5Schemes, rules and methods of doing business, performing purely mental acts or playing games
3.6Programs for computers
3.7Presentations of information
4.Exceptions to patentability
4.1Matter contrary to public order or morality
4.2Surgery, therapy and diagnostic methods
5.Exclusions and exceptions for biotechnological inventions
5.1General remarks and definitions
5.2Biotechnological inventions
5.3Exceptions
5.4Plant and animal varieties, essentially biological processes for the production of plants or animals
5.5Microbiological processes
Chapter III – Industrial application
1.General remarks
2.Methodology
3.Industrial applicability
Chapter IV – Prior art
1.General remarks and definition
2.Enabling disclosures
3.Date of filing or priority date as effective date
4.Documents in a non‑official language of the (S)ISA or IPEA
4.1Machine translations
5.Conflict with other applications
5.1Prior art pursuant to Rules 33.1(c) and 64.3
5.2Co-pending applications
6.Prior art made available to the public anywhere in the world by non-written disclosure
6.1Types of non-written disclosure, in particular use, and instances of prior art made available in any other way
6.2Matters to be determined as regards use
6.2.1General principles
6.2.2Agreement on secrecy
6.2.3Use on non-public property
6.2.4Example of the accessibility of objects used
6.2.5Example of the inaccessibility of a process
6.3Prior art made available by means of oral description
6.4Internet disclosures
6.5Standards and standard preparatory documents
7.Cross‑references between prior-art documents
8.Errors in prior-art documents
Chapter V – Non-prejudicial disclosures
1.General
Chapter VI – Novelty
1.Prior art pursuant to Art. 33(2)
2.Implicit features or well-known equivalents
3.Relevant date of a prior document
4.Enabling disclosure of a prior document
5.Generic disclosure and specific examples
6.Implicit disclosure and parameters
7.Examination of novelty
7.1Second or further medical use of known pharmaceutical products
7.2Second non‑medical use
8.Selection inventions
9.Novelty of "reach-through" claims
Chapter VII – Inventive step
1.General
2.Prior art; date of filing, date of priority
3.Person skilled in the art
3.1Common general knowledge of the skilled person
4.Obviousness
5.Problem‑solution approach
5.1Determination of the closest prior art
5.2Formulation of the objective technical problem
5.3Could‑would approach
5.4Claims comprising technical and non‑technical features
5.4.1Formulation of the objective technical problem for claims comprising technical and non-technical features
5.4.2Examples of applying the steps listed in GL/EPO G‑VII, 5.4
6.Combining pieces of prior art
7.Combination vs. juxtaposition or aggregation
8.Ex post facto analysis
9.Origin of an invention
10.Secondary indicators
10.1Predictable disadvantage; non-functional modification; arbitrary choice
10.2Unexpected technical effect; bonus effect
10.3Long felt need; commercial success
11.Arguments and evidence submitted by the applicant
12.Selection inventions
13.Dependent claims; claims in different categories
14.Examples
 
 

Source: http://www.epo.org/law-practice/legal-texts/html/guidelinespct/e/g.htm

Date retrieved: 17 May 2021

90 references found.

Click X to load a reference inside the current page, click on the title to open in a new page.

EPO PCT GL - C Procedureal Aspects Chapter II

EPO PCT GL - F (not assigned)

EPO PCT GL - G Patentability